Investor directory

Norwich Ventures

Norwich Ventures is a venture capital firm based in Waltham, Massachusetts, with additional offices in Pennsylvania and Cambridge, focused on early-stage investments in the medtech and healthcare sectors. Founded in 2004, the firm targets entrepreneurs developing innovative technologies that address significant unmet medical needs, primarily investing in seed and early-stage rounds. Norwich Ventures typically seeks opportunities for initial investment in companies located in the New England and Mid-Atlantic regions, although it also considers investments in other areas. The firm emphasizes long-term support for its portfolio companies, often being the first institutional investor and focusing on patentable technologies that have the potential to drive substantial advancements in healthcare.

Focus

Series AEarly VentureScale StageSeries BLaserShow more
http://www.norwichventures.com
http://www.norwichventures.com
https://app.dealroom.co/companies/norwich_ventures
https://crunchbase.com/organization/norwich-ventures
https://linkedin.com/company/norwich-ventures
https://pitchbook.com/profiles/investor/42857-74
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=26015149
https://www.privateequityinternational.com/database/#/profile?id=14509

Philip Fleck

Director

Marlin Miller

Co-Founder and Senior Advisor

Aaron Sandoski

Co-Founder & Managing Director

James Watkins

Advisor

21 past transactions

Affera, Inc.

Series A in 2017
Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia, a prevalent condition affecting millions of patients worldwide.

Vaxess Technologies

Series A in 2013
Vaxess Technologies, Inc., a biotechnology company, develops and commercializes silk biomaterial technologies. It offers MIMIX microneedle platform for transdermal delivery of vaccines and therapies; and MATRIX formulation and drying platform for the development of thermostable vaccine, therapeutic, and diagnostic products. The company was founded in 2011 and is based in Boston, Massachusetts.

Lexington Medical, Inc.

Series A in 2016
We are a Boston-based medical device company that manufactures minimally invasive surgical stapling solutions. With the highest standards in design engineering and smart manufacturing, our specialized team is committed to delivering disruptive innovation to health care providers and their patients.

Rhythmia Medical

Series B in 2007
Rhythmia Medical, Inc., an early stage medical device company, develops medical devices for the treatment of cardiac arrhythmia. It focuses on developing a 3D mapping system to enable an improvement in the catheter ablation procedures used to treat tachy-arrhythmias, such as atrial fibrillation.

Arterys

Series A in 2015
Arterys is the market leader and the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions.

Arterys

Series A in 2016
Arterys is the market leader and the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions.

Syncro Medical Innovations

Debt Financing in 2010
Syncro Medical Innovations, Inc. develops magnetically guided enteral feeding tubes. The company’s feeding tube contains magnetic field sensor at the distal end, electrically connected to a light indicator at the proximal end of the tube. Syncro Medical Innovations, Inc. was founded in 1998 and is based in Macon, Georgia.

Ionpath

Series B in 2020
Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen, or FFPE that enable healthcare providers to provide a diagnosis of cancer for improving human health.

Svelte Medical Systems

Debt Financing in 2009
Svelte Medical Systems (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Its mission is to address key clinical issues in the stent market by improving stent deliverability, reducing cost, and dramatically improving the safety of the device compared to current market products. Svelte has developed the lowest profile and most deliverable balloon-expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug-Eluting Stent (DES). Svelte was started by Robert Fischell, David Fischell, and Tim Fischell in 2007.

Intelligent Bio-Systems

Series A in 2008
Intelligent Bio-Systems was founded in 2005 by Drs. Steven J. Gordon and Jingyue Ju to commercialize an advanced DNA sequencing system. Dr. Gordon previously founded Intelligent Automation Systems, which was responsible for a number of key instrumentation solutions which helped to complete the Human Genome Project. Dr. Ju is one of the key inventors of fluorescent energy transfer dyes used in most electrophoresis-based sequencers.

Syncro Medical Innovations

Series A in 2006
Syncro Medical Innovations, Inc. develops magnetically guided enteral feeding tubes. The company’s feeding tube contains magnetic field sensor at the distal end, electrically connected to a light indicator at the proximal end of the tube. Syncro Medical Innovations, Inc. was founded in 1998 and is based in Macon, Georgia.

Podimetrics

Private Placement in 2020
Podimetrics, Inc. develops remote temperature monitoring systems for the prevention of diabetic foot ulcers. It offers Podimetrics SmartMat, a wireless in-home monitoring technology that collects foot temperature scans. The company also offers online tools for clinical decision support and population management. Podimetrics, Inc. was founded in 2011 and is based in Somerville, Massachusetts.

Podimetrics

Private Placement in 2019
Podimetrics, Inc. develops remote temperature monitoring systems for the prevention of diabetic foot ulcers. It offers Podimetrics SmartMat, a wireless in-home monitoring technology that collects foot temperature scans. The company also offers online tools for clinical decision support and population management. Podimetrics, Inc. was founded in 2011 and is based in Somerville, Massachusetts.

ReThink Medical

Series A in 2017
ReThink Medical, Inc. manufactures wrist-worn devices that measure, detect, and notify indicators of worsening heart failures. It detects and notifies worsening conditions of heart and heart failure weeks in advance that allows proper treatment preventing hospitalization. The company was founded in 2010 and is based in San Francisco, California. As of August 11, 2020, ReThink Medical, Inc. operates as a subsidiary of Terumo Corporation.

Podimetrics

Series B in 2019
Podimetrics, Inc. develops remote temperature monitoring systems for the prevention of diabetic foot ulcers. It offers Podimetrics SmartMat, a wireless in-home monitoring technology that collects foot temperature scans. The company also offers online tools for clinical decision support and population management. Podimetrics, Inc. was founded in 2011 and is based in Somerville, Massachusetts.

Ionpath

Private Placement in 2020
Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen, or FFPE that enable healthcare providers to provide a diagnosis of cancer for improving human health.

Soffio Medical

Series A in 2016
Soffio Medical is a medical company that develops medical apparatus for respiratory diseases. The company is based in Boston, Massachusetts.

Daktari Diagnostics

Series D in 2015
Daktari Diagnostics, Inc., a healthcare solutions company, develops and provides portable point-of-care diagnostic platforms for disease management Worldwide. It offers Daktari Virology, a platform for HCV and HIV detection; Daktari InSight, a data management service that connects Daktari’s systems to its customers; and Daktari Sickle Cell, a solution that provides tests to identify infants with sickle cell disease from a drop of blood. The company was founded in 2008 and is based in Cambridge, Massachusetts.

Daktari Diagnostics

Series A in 2009
Daktari Diagnostics, Inc., a healthcare solutions company, develops and provides portable point-of-care diagnostic platforms for disease management Worldwide. It offers Daktari Virology, a platform for HCV and HIV detection; Daktari InSight, a data management service that connects Daktari’s systems to its customers; and Daktari Sickle Cell, a solution that provides tests to identify infants with sickle cell disease from a drop of blood. The company was founded in 2008 and is based in Cambridge, Massachusetts.

Daktari Diagnostics

Series B in 2011
Daktari Diagnostics, Inc., a healthcare solutions company, develops and provides portable point-of-care diagnostic platforms for disease management Worldwide. It offers Daktari Virology, a platform for HCV and HIV detection; Daktari InSight, a data management service that connects Daktari’s systems to its customers; and Daktari Sickle Cell, a solution that provides tests to identify infants with sickle cell disease from a drop of blood. The company was founded in 2008 and is based in Cambridge, Massachusetts.